Covered recipient · General Payments record
SADIQ H MANDILAWI
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$3,742.75
- Reported across 182 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $358.86 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $109.70 | 2 |
| Lilly USA, LLC | $62.19 | 3 |
| Insulet Corporation | $33.91 | 1 |
| SANOFI-AVENTIS U.S. LLC | $26.64 | 2 |
| Radius Health, Inc. | $25.79 | 1 |
| Ascendis Pharma Inc | $23.95 | 1 |
| Madrigal Pharmaceuticals | $20.59 | 1 |
| Amphastar Pharmaceuticals, Inc. | $20.55 | 1 |
| Novo Nordisk AS | $19.08 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $16.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. | $20.55 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149953126 | CMS |
| Ascendis Pharma Inc | $23.95 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133850155 | CMS |
| Insulet Corporation | $33.91 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116792734 | CMS |
| Lilly USA, LLC | $15.42 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135361180 | CMS |
| Lilly USA, LLC | $25.93 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135409961 | CMS |
| Lilly USA, LLC | $20.84 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135361182 | CMS |
| Madrigal Pharmaceuticals | $20.59 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144175065 | CMS |
| Medtronic, Inc. | $73.22 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117148748 | CMS |
| Medtronic, Inc. | $36.48 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117148746 | CMS |
| Novo Nordisk Inc | $19.08 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597016 | CMS |
| Radius Health, Inc. | $25.79 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089989283 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $16.46 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139164520 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.48 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139599485 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.16 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139599585 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.